• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    4/2/24 1:23:42 PM ET
    $ACON
    $ACOR
    $ADTX
    $AGL
    Medical Specialities
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACON alert in real time by email

    Shares of Stryve Foods, Inc. (NASDAQ:SNAX) fell sharply during Tuesday’s session following a fourth-quarter revenue miss.

    Stryve Foods posted adjusted loss of $1.90 per share, versus market estimates for a loss of $1.96 per share. The company’s sales came in at $2.887 million versus expectations of $5.009 million, according to data from Benzinga Pro.

    Stryve Foods shares dipped 25.2% to $1.0965 on Tuesday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • VivoPower International PLC (NASDAQ:VVPR) shares surged 315% to $6.10 after the company's Tembo subsidiary announced it will merge with the Nasdaq-listed Cactus Acquisition Corp. 1 Limited.
    • Trio Petroleum Corp. (NYSE:TPET) gained 73.8% to $0.1797 after jumping over 21% on Monday.
    • XTI Aerospace, Inc. (NASDAQ:XTIA) rose 63.9% to $3.3750 after jumping 19% on Monday.
    • Kidpik Corp. (NASDAQ:PIK) shares climbed 35.2% to $5.90 after the company entered a merger agreement with Nina Footwear.
    • VirTra, Inc. (NASDAQ:VTSI) rose 32.8% to $12.67 after the company reported better-than-expected fourth-quarter results.
    • MSP Recovery, Inc. (NASDAQ:LIFW) gained 26.9% to $0.8449 after a 13G filing showed Palantir Technologies reported a 6.5% stake in the company as of March 22, 2024.
    • Aditxt, Inc. (NASDAQ:ADTX) gained 20% to $3.8204 after the company announced it will acquire Appili Therapeutics.
    • TMC the metals company Inc. (NASDAQ:TMC) climbed 18.1% to $1.70.
    • C3is Inc. (NASDAQ:CISS) rose 18% to $0.0426.
    • Nexalin Technology, Inc. (NASDAQ:NXL) gained 18% to $2.2400. Nexalin Technology announced the appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board.
    • Concord Medical Services Holdings Limited (NYSE:CCM) rose 17.7% to $0.6119.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) gained 10.7% to $4.43.
    • Yatsen Holding Limited (NYSE:YSG) rose 10% to $2.52.
    • ChampionX Corporation (NASDAQ:CHX) gained 9.5% to $38.78 after SLB announced it will acquire the company.
    • Canopy Growth Corporation (NASDAQ:CGC) rose 8.2% to $8.15.
    • SIGA Technologies, Inc. (NASDAQ:SIGA) gained 7.4% to $9.45. SIGA Technologies entered amendment to its international promotion agreement with Meridian Medical.

    Losers

    • Acorda Therapeutics, Inc. (NASDAQ:ACOR) shares dipped 83.5% to $2.1999 after the company commenced voluntary proceedings under Chapter 11 of the United States Bankruptcy Code.
    • Gritstone bio, Inc. (NASDAQ:GRTS) dipped 47% to $1.2450 after the company announced a $32.5 million underwritten public offering of 8,333,333 shares of common stock and accompanying common warrants at $1.50 per share and accompanying common warrant.
    • Orgenesis Inc. (NASDAQ:ORGS) fell 39.8% to $0.3499.
    • Verve Therapeutics, Inc. (NASDAQ:VERV) dipped 37.7% to $7.96 amid the company pausing enrollment in its Heart-1 Phase 1b clinical trial after a participant experienced a Grade 3 drug-induced transient increase in serum alanine aminotransferase as well as a serious adverse event.
    • Microvast Holdings, Inc. (NASDAQ:MVST) fell 32.1% to $0.6078 after announcing fourth-quarter financial results.
    • Binah Capital Group, Inc. (NASDAQ:BCG) dipped 31.2% to $7.11.
    • Canoo Inc. (NASDAQ:GOEV) fell 28.7% to $2.7593 after the company issued weak 2024 revenue guidance.
    • CXApp Inc. (NASDAQ:CXAI) declined 26.8% to $4.50, pulling back after the stock rallied on Monday following a Google Cloud partnership.
    • Pioneer Power Solutions, Inc. (NASDAQ:PPSI) fell 25.8% to $4.40 after reporting unaudited preliminary financial results for the fourth quarter and 12 months ended Dec. 31, 2023.
    • Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) fell 23.8% to $1.0650 following weak quarterly results.
    • Yield10 Bioscience, Inc. (NASDAQ:YTEN) dipped 23.5% to $0.2933 following quarterly results.
    • PVH Corp. (NYSE:PVH) fell 23.3% to $107.19 after the company reported fourth-quarter financial results and issued guidance.
    • Aclarion, Inc. (NASDAQ:ACON) shares tumbled 21.8% to $0.3205 after jumping 24% on Monday. Aclarion received a Notice of Allowance for its U.S. patent application 18/190,723 titled "Magnetic Resonance Spectroscopy Pulse Sequence, Acquisition, And Processing System And Method (For Diagnosing Pain)."
    • GCT Semiconductor Holding, Inc. (NASDAQ:GCTS) shares fell 19.6% to $14.53 after declining over 45% on Monday. GCT Semiconductor appointed Nelson C. Chan to Board of Directors.
    • Allego N.V. (NYSE:ALLG) fell 18.4% to $1.25. Allego postponed fourth quarter And full year 2023 financial results conference call.
    • AST SpaceMobile, Inc. (NASDAQ:ASTS) declined 17.4% to $2.1724 after the company reported worse-than-expected fourth quarter EPS results.
    • Tritium DCFC Limited (NASDAQ:DCFC) declined 15.5% to $8.50.
    • Cipher Mining Inc. (NASDAQ:CIFR) fell 15% to $4.15 amid a drop in Bitcoin.
    • Humana Inc. (NYSE:HUM) shares fell 13.8% to $302.65 after the Centers for Medicare & Medicaid Services (CMS) finalized payment updates. The CMS announced Monday that it finalized the calendar year 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) programs that updates payment policies for these programs and ensures payment accuracy.
    • AERWINS Technologies Inc. (NASDAQ:AWIN) declined 12.1% to $5.80.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) fell 11% to $15.93. Avalo Therapeutics shares fell around 18% on Monday after the company reported worse-than-expected FY23 EPS results.
    • Fractyl Health, Inc. (NASDAQ:GUTS) shares dipped 10.7% to $6.64 amid volatility after the company reported fourth-quarter financial results.
    • HWH International Inc. (NASDAQ:HWH) shares fell 10.5% to $0.8450 after falling 5% on Monday.
    • agilon health, inc. (NYSE:AGL) fell 9.6% to $5.28.
    • QuidelOrtho Corporation (NASDAQ:QDEL) fell 8.5% to $43.01. QuidelOrtho receives FDA clearance for QuickVue COVID-19 test.
    • CVS Health Corporation (NYSE:CVS) shares declined 8.2% to $73.00 after the Centers for Medicare & Medicaid Services (CMS) finalized payment updates.
    • CleanSpark, Inc. (NASDAQ:CLSK) fell 7.9% to $17.11 amid a drop in Bitcoin.
    • RH (NYSE:RH) fell 7.3% to $310.31. Goldman Sachs analyst Kate McShane maintained RH with a Sell and raised the price target from $201 to $264.
    • MicroStrategy Incorporated (NASDAQ:MSTR) shares declined 7.2% to $1,518.97 amid a decline in Bitcoin.
    • UnitedHealth Group Incorporated (NYSE:UNH) fell 7.2% to $454.44 on the heels of finalized payment updates from the Centers for Medicare & Medicaid Services (CMS).

     

    Now Read This: Bitcoin Falls Below $66,000; Axelar Becomes Top Loser

    Get the next $ACON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACON
    $ACOR
    $ADTX
    $AGL

    CompanyDatePrice TargetRatingAnalyst
    UnitedHealth Group Incorporated
    $UNH
    4/1/2026$330.00Mkt Perform → Outperform
    Raymond James
    Canopy Growth Corporation
    $CGC
    3/27/2026Buy
    Canaccord Genuity
    RH
    $RH
    3/25/2026$185.00 → $165.00Market Perform
    Telsey Advisory Group
    PVH Corp.
    $PVH
    3/24/2026$82.00 → $74.00Market Perform
    Telsey Advisory Group
    CVS Health Corporation
    $CVS
    3/12/2026$94.00Mkt Perform → Outperform
    Bernstein
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    Humana Inc.
    $HUM
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    Cipher Digital Inc.
    $CIFR
    2/9/2026$38.00Overweight
    Morgan Stanley
    More analyst ratings

    $ACON
    $ACOR
    $ADTX
    $AGL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    Omnicare Advances Court-Supervised Process While Continuing to Deliver Enhanced Value to Customers

    Enters into Asset Purchase Agreement with GenieRx WOONSOCKET, R.I., April 1, 2026 /PRNewswire/ -- Omnicare, LLC (the "Company" or "Omnicare"), a subsidiary of CVS Health (NYSE:CVS), today announced it has entered into an asset purchase agreement with GenieRx Holdings LLC ("GenieRx"), a joint partnership between private investment firm Milrose Capital LLC and health-care investment and management firm Integro Asset Management LLC, which does business as Integro Healthcare Services. GenieRx will serve as the "stalking horse bidder" in the Company's ongoing court‑supervised sale process.

    4/1/26 3:07:00 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    PVH Corp. Reports 2025 Fourth Quarter Revenue and Earnings Above Guidance; Provides 2026 Outlook

    Delivered strong fourth quarter and finish to the year; fourth quarter revenue exceeded guidance, increasing 6% on a reported basis (flat in constant currency), with full year revenue in line with guidance, up 3% on a reported basis (up slightly in constant currency) Generated fourth quarter operating margin of 9.9% on a GAAP basis and 10.0% on a non-GAAP basis including an approximately 170 basis point negative impact of gross tariffs, exceeding guidance of approximately 9% Generated full year operating margin of 2.6% on a GAAP basis and 8.8% on a non-GAAP basis including an approximately 80 basis point negative impact of gross tariffs, exceeding guidance of approximately 8.5% Le

    3/31/26 4:15:00 PM ET
    $PVH
    Garments and Clothing
    Industrials

    $ACON
    $ACOR
    $ADTX
    $AGL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth upgraded by Raymond James with a new price target

    Raymond James upgraded UnitedHealth from Mkt Perform to Outperform and set a new price target of $330.00

    4/1/26 8:15:26 AM ET
    $UNH
    Medical Specialities
    Health Care

    Canaccord Genuity initiated coverage on Canopy Growth

    Canaccord Genuity initiated coverage of Canopy Growth with a rating of Buy

    3/27/26 8:46:41 AM ET
    $CGC
    Medicinal Chemicals and Botanical Products
    Health Care

    Telsey Advisory Group reiterated coverage on RH with a new price target

    Telsey Advisory Group reiterated coverage of RH with a rating of Market Perform and set a new price target of $165.00 from $185.00 previously

    3/25/26 8:14:41 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $ACON
    $ACOR
    $ADTX
    $AGL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/18/21 5:24:40 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE

    Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:

    1/15/21 11:16:15 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $ACON
    $ACOR
    $ADTX
    $AGL
    SEC Filings

    View All

    SEC Form PRE 14A filed by Aclarion Inc.

    PRE 14A - Aclarion, Inc. (0001635077) (Filer)

    4/3/26 5:02:23 PM ET
    $ACON
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Aditxt Inc.

    DEF 14A - Aditxt, Inc. (0001726711) (Filer)

    4/3/26 4:37:32 PM ET
    $ADTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by CVS Health Corporation

    DEF 14A - CVS HEALTH Corp (0000064803) (Filer)

    4/3/26 4:05:26 PM ET
    $CVS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $ACON
    $ACOR
    $ADTX
    $AGL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Schwaneke Jeffrey A.

    4 - agilon health, inc. (0001831097) (Issuer)

    4/3/26 7:40:29 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Shaker Benjamin

    4 - agilon health, inc. (0001831097) (Issuer)

    4/3/26 7:39:18 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Gertsch Timothy

    4 - agilon health, inc. (0001831097) (Issuer)

    4/3/26 7:38:25 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    $ACON
    $ACOR
    $ADTX
    $AGL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Markets Officer Shaker Benjamin bought $301,050 worth of shares (500,000 units at $0.60), increasing direct ownership by 58% to 1,367,674 units (SEC Form 4)

    4 - agilon health, inc. (0001831097) (Issuer)

    3/3/26 5:28:28 PM ET
    $AGL
    Misc Health and Biotechnology Services
    Health Care

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    Amendment: Chief Financial Officer Busky Joseph M. bought $79,742 worth of shares (3,370 units at $23.66) (SEC Form 4)

    4/A - QuidelOrtho Corp (0001906324) (Issuer)

    2/19/26 4:18:05 PM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $ACON
    $ACOR
    $ADTX
    $AGL
    Leadership Updates

    Live Leadership Updates

    View All

    Critical Minerals Boom: Nickel–Cobalt Market Races Toward $35B+ Valuation

    NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Nickel–cobalt alloys might not sound exciting at first, but they're actually a big deal in modern defense. These materials are used in things like jet engines, missile systems, and naval equipment because they can handle extreme heat and stress without breaking down. That's why governments are starting to treat nickel and cobalt as must-have resources, not just commodities. There's also a growing push to secure supply closer to home, since a lot of global production is concentrated in a few regions—something that makes defense planners (and investors) a bit uneasy.   Active Companies mentioned in the article

    3/31/26 8:45:00 AM ET
    $ALOY
    $MP
    $TMC
    Metal Mining
    Basic Materials

    Tommy Hilfiger Welcomes American Football Icon Travis Kelce as Global Brand Ambassador and Creative Collaborator

    One of sport's biggest stars on and off the field, Travis Kelce steps into Tommy Hilfiger's world of Classic American Cool — in a series of campaigns, collaborations and events spanning F.A.M.E.S (Fashion, Art, Music, Entertainment and Sport). The multi-season partnership will showcase co-designed menswear and accessories refreshing "Prep Made Current" through Travis Kelce's vibrant lens. Tommy Hilfiger, which is part of PVH Corp. (NYSE:PVH), announces Travis Kelce — three-time Super Bowl champion and defining voice of his generation — as Global Brand Ambassador and creative collaborator. Inspired by its 40 years of collaborating with trailblazing figures across pop culture, Tommy Hilfi

    3/30/26 8:00:00 AM ET
    $PVH
    Garments and Clothing
    Industrials

    RH Announces the Appointment of Veronica Schnitzius as President, Chief Manufacturing & Sourcing Officer

    RH (NYSE:RH) announced today that Veronica Schnitzius is joining the Company as President, Chief Manufacturing & Sourcing Officer. Veronica will lead RH's efforts to build a global manufacturing platform that combines owned and operated, joint-ventured, and outsourced manufacturing for the Company's core furniture business, which represents 80% of RH brand revenues. The strategy will emulate the vertically integrated model of many of the world's largest and most profitable luxury brands that have a high level of control over the manufacturing, quality and capacity of their core business. Mrs. Schnitzius joins RH after a distinguished 24-year career at American Leather, a leading U.S. br

    3/27/26 8:00:00 AM ET
    $RH
    Other Specialty Stores
    Consumer Discretionary

    $ACON
    $ACOR
    $ADTX
    $AGL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by QuidelOrtho Corporation

    SC 13G/A - QuidelOrtho Corp (0001906324) (Subject)

    12/6/24 10:11:24 AM ET
    $QDEL
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by Orgenesis Inc.

    SC 13G/A - Orgenesis Inc. (0001460602) (Subject)

    12/4/24 6:51:18 PM ET
    $ORGS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACON
    $ACOR
    $ADTX
    $AGL
    Financials

    Live finance-specific insights

    View All

    The Only Mach 2+ Commercial Fleet in the World Is Now Testing Reusable Hypersonic Space Systems -- and the Pentagon Is Writing the Checks

    Issued on behalf of Starfighters Space, Inc.CAPE CANAVERAL, Fla., April 2, 2026 /CNW/ -- USA News Group News Commentary — The next arms race isn't being fought on the ground. It's being fought at 45,000 feet and Mach 2, in the stratosphere where hypersonic weapons are validated, reusable space systems are tested, and the gap between the United States and its adversaries is either closed or conceded. The Pentagon knows it. Congress knows it. And the capital flowing into the commercial aerospace sector right now reflects exactly that urgency. The U.S. Space Force is operating on a

    4/2/26 2:02:00 PM ET
    $ASTS
    $FJET
    $LUNR
    Telecommunications Equipment
    Consumer Discretionary
    Air Freight/Delivery Services
    Industrial Machinery/Components

    PVH Corp. Reports 2025 Fourth Quarter Revenue and Earnings Above Guidance; Provides 2026 Outlook

    Delivered strong fourth quarter and finish to the year; fourth quarter revenue exceeded guidance, increasing 6% on a reported basis (flat in constant currency), with full year revenue in line with guidance, up 3% on a reported basis (up slightly in constant currency) Generated fourth quarter operating margin of 9.9% on a GAAP basis and 10.0% on a non-GAAP basis including an approximately 170 basis point negative impact of gross tariffs, exceeding guidance of approximately 9% Generated full year operating margin of 2.6% on a GAAP basis and 8.8% on a non-GAAP basis including an approximately 80 basis point negative impact of gross tariffs, exceeding guidance of approximately 8.5% Le

    3/31/26 4:15:00 PM ET
    $PVH
    Garments and Clothing
    Industrials

    Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

    Humana Inc. (NYSE:HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 1Q26 earnings call may be accessed via Humana's Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BId1413c4c078343e28841e18c372f7b58.

    3/30/26 4:30:00 PM ET
    $HUM
    Medical Specialities
    Health Care